IMS Health

Last updated
Ims Health Inc.
Type Subsidiary
Industry Healthcare,
Information Services, Technology
Founded1954 as Information Medical Statistics
FateMerged with Quintiles to form IQVIA
SuccessorIQVIA
Headquarters Danbury, Connecticut, USA
Durham, North Carolina, USA
ProductsHealthcare Measurement, Analytics & Services, Consulting, Technology Services
Revenue$2.64B [1] (2015)
Number of employees
14,000+ [1] (2015)
Website iqvia.com

IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. [2] [3] [4] IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. [5] In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. [6] The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS. [1] [7] IMS Health was headquartered in Danbury, Connecticut.

Contents

Over 2016 Quintiles and IMS Health merged, and the resulting company was named QuintilesIMS, which was renamed to IQVIA in 2017.

Business model

IMS Health was best known for its collection of healthcare information spanning sales, de-identified prescription data, medical claims, electronic medical records [8] and social media. [9] IMS Health's products and services were used by companies to develop commercialization plans [10] and portfolio strategies, [11] to select patient and physician populations for specific therapies, and to measure the effectiveness of pharmaceutical marketing and sales resources. [12] The firm uses its own data to produce syndicated reports such as market forecasts and market intelligence.

History and acquisitions

The original name of the company was Intercontinental Marketing Statistics, hence the IMS name. IMS Health's corporate headquarters is located in Danbury, Connecticut, United States. The company's chairman and CEO is Ari Bousbib.

Controversy

Throughout its history, IMS Health's business of collecting anonymized pharmaceutical sales data came under scrutiny from both the media and the legal system. [27]

IMS Health v. Ayotte was a free speech case involving IMS Health. [28] [29] [30]

Sorrell v. IMS Health Inc. was a case about physician-data privacy, which went to the U.S. Supreme Court., the High Court ruled in favor of the company. [31] [32] [33] [34]

Related Research Articles

Customer relationship management (CRM) is a process in which a business or other organization administers its interactions with customers, typically using data analysis to study large amounts of information.

Cognizant is an American multinational information technology services and consulting company. It is headquartered in Teaneck, New Jersey, U.S. Cognizant is part of the NASDAQ-100 and trades under CTSH. It was founded as an in-house technology unit of Dun & Bradstreet in 1994, and started serving external clients in 1996.

Pharmaceutical marketing is a branch of marketing science and practice focused on the communication, differential positioning and commercialization of pharmaceutical products, like specialist drugs, biotech drugs and over-the-counter drugs. By extension, this definition is sometimes also used for marketing practices applied to nutraceuticals and medical devices.

Wolters Kluwer N.V. is a Dutch information services company. The company is headquartered in Alphen aan den Rijn, Netherlands (Global) and Philadelphia, United States (corporate). Wolters Kluwer in its current form was founded in 1987 with a merger between Kluwer Publishers and Wolters Samsom. The company serves legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare markets. It operates in over 150 countries.

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook, operates the Parexel-Academy, and councils all of the top 50 biopharmaceutical and top 30 biotechnology companies.

IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).

Real Chemistry, formerly known as W2O Group, is a global health innovation company that utilizes artificial intelligence (AI) for its healthcare services. Founded by Jim Weiss in 2001, Real Chemistry is an American company with global offices in Europe and Canada.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Sorrell v. IMS Health Inc., 564 U.S. 552 (2011), is a United States Supreme Court case in which the Court held that a Vermont statute that restricted the sale, disclosure, and use of records that revealed the prescribing practices of individual doctors violated the First Amendment.

Hugo Stephenson is an Australian doctor, biotech services entrepreneur and founder of MediGuard, Health Research Solutions and MedSeed. Hugo is best known for his work promoting drug safety research and consumer health awareness.

Healthcare CRM, also known as Healthcare Relationship Management, is a broadly used term for a Customer relationship management system, or CRM, used in healthcare.

EMIS Health, formerly known as Egton Medical Information Systems, supplies electronic patient record systems and software used in primary care, acute care and community pharmacy in the United Kingdom. The company is based in Leeds. It claims that more than half of GP practices across the UK use EMIS Health software and holds number one or two market positions in its main markets. In June 2022 the company was acquired by Bordeaux UK Holdings II Limited, an affiliate of UnitedHealth’s Optum business for a 49% premium on EMIS’s closing share price.

<span class="mw-page-title-main">ZS Associates</span> American management consulting firm

ZS Associates is a management consulting and professional services firm focusing on consulting, software, and technology, headquartered in Evanston, Illinois that provides services for clients in healthcare, private equity, and technology. The firm was founded in 1983 by two professors at Northwestern University who developed sales force alignment models using the world’s first personal-computer-aided territory mapping system. ZS continues to offer sales force alignment service to this day, in addition to a range of professional services, many of which are supported by advanced analytics.

<span class="mw-page-title-main">Dennis Gillings</span>

Sir Dennis Barry Gillings is an American-based British billionaire statistician and entrepreneur, the founder and former chairman of Quintiles Transnational, a clinical research company, headquartered in Durham, North Carolina.

Health Data Insight (HDI) CiC is a social enterprise, that researches and data mines NHS England figures to find population health and epidemiological or demographic insights for effective NHS treatments by public health informatics, headquartered in the east of Cambridge.

Linguamatics, headquartered in Cambridge, England, with offices in the United States and UK, is a provider of text mining systems through software licensing and services, primarily for pharmaceutical and healthcare applications. Founded in 2001, the company was purchased by IQVIA in January 2019.

Cegedim SA is a health technology company based in Boulogne-Billancourt, founded in 1969. It employs more than 4,200 people in more than 10 countries. Revenue in 2017 was €457 million.

ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, California. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

<span class="mw-page-title-main">Pharmaceutical Advertising Advisory Board</span> Canadian not-for-profit organization

The Pharmaceutical Advertising Advisory Board (PAAB) is a Canadian not-for-profit organization based in Pickering, Ontario. Acting as a pseudo-regulatory body, PAAB offers review and pre-clearance services recognized by Health Canada to pharmaceutical companies and marketing agencies who wish to advertise directly to consumers and/or healthcare professionals. It is financed on a fee-for-service basis.

References

  1. 1 2 3 IMS Health Annual Report (10-K), 2014
  2. 1 2 Steinbrook, R (Jun 29, 2006). "For sale: physicians' prescribing data". The New England Journal of Medicine. 354 (26): 2745–7. doi:10.1056/nejmp068125. PMID   16807410.
  3. Fugh-Berman, A (August 2008). "Prescription tracking and public health". Journal of General Internal Medicine. 23 (8): 1277–80. doi:10.1007/s11606-008-0630-0. PMC   2517975 . PMID   18473146.
  4. Fugh-Berman, A; Ahari, S (April 2007). "Following the script: how drug reps make friends and influence doctors". PLOS Medicine. 4 (4): e150. doi: 10.1371/journal.pmed.0040150 . PMC   1876413 . PMID   17455991.
  5. "The Real Arthur Sackler. Part 4: Visionary Data Crook". 25 September 2019.
  6. "IMS Health sold to TPG, CPPIB, LG&P"
  7. Picker, Leslie (2014-04-04). "TPG-Backed IMS Health Gains After $1.3 Billion Share Sale". BloombergBusiness.
  8. "What Does IMS Health Do, Anyway?". The Wall Street Journal. 5 November 2009.
  9. Munro, Dan. "New Study Ranks Johnson & Johnson #1 In Pharma For Social Media Engagement". Forbes.
  10. Drive to Develop New Commercial Models.pdf "The Drive to Develop New Commercial Models"
  11. in the News/Documents/Kleinrock, 2011 CA Biomed Industry Report_FINAL.pdf "CA Biomed Industry Report"
  12. Market Maps TL.pdf "Patient Market Maps"
  13. "The Business Week 50" Bloomberg Business Week, Accessed 20 October 2010
  14. "TPG and Pension Plan to Buy IMS Health" New York Times Deal Book, 5 November 2009
  15. Leuty, Ron (24 April 2012). "IMS Health to buy clinical trials software company Decision View". San Francisco Business Times. Retrieved 2020-11-16.
  16. Conn, Joseph (2012-08-15). "IMS acquires analytics company TTC". Modern Healthcare. Retrieved 2020-11-16.
  17. "IMS Health Expands Suite of Syndicated, Web-based Analytics With Acquisition of PharmaDeals Ltd". FiercePharma. 14 August 2012. Retrieved 2020-11-16.
  18. "IMS Health Acquires Dataline Software, Extending Real-World Evidence Technology Platform and Application Suite". IMS Health. 2015-11-11. Retrieved 2017-05-25.
  19. "Cegedim completes disposal of the CRM and Strategic Data Division to IMS Health" (PDF). 1 April 2015.
  20. "Acquisition announcement" (PDF).
  21. "Quintiles is merging with IMS in a deal worth about $9 billion - Fortune". Fortune. Reuters. 3 May 2016.
  22. "Quintiles, IMS Health Plan $9B Merger". GEN. 3 May 2016.
  23. Kristen Hallam; Zachary Tracer (3 May 2016). "IMS Health to Buy Quintiles in $9 Billion Pharma Data Deal". Bloomberg.com.
  24. Erik Holm (3 May 2016). "Deals of the Day: IMS Health Merges With Quintiles, Biogen to Spin Off Hemophilia Arm". WSJ.
  25. Henderson, Jennifer (3 October 2016). "Quintiles, IMS Health complete merger". Triangle Business Journal, American City Business Journals. Retrieved 3 October 2016.
  26. "QuintilesIMS is now IQVIA". Business Wire. 6 November 2017. Retrieved 6 November 2017.
  27. "Company that Knows What Drugs Everyone Takes Going Public". Forbes.
  28. Baxter, Alexander D. "IMS Health v. Ayotte: A New Direction on Commercial Speech Cases" (PDF). Berkeley Technology Law Journal . 25 (1): 649–670. Archived from the original (PDF) on 5 November 2010. Retrieved 5 February 2014.
  29. Shapiro, Ilya (28 April 2009). "IMS Health v. Ayotte | Cato Institute". cato.org. Cato Institute . Retrieved 5 February 2014.
  30. Bibet-Kalinyak, Isabelle (2012). "Critical Analysis of Sorrell v. IMS Health, Inc.: Pandora's Box at Best". Food & Drug L.J. 67 (2): 191–241, ii. PMID   24620419.
  31. "IMS Health Wins Court Attack on Vermont Marketing Law". Bloomberg. 23 November 2010.
  32. Law360 11 August, 2011. Inside Sorrell V. IMS Health
  33. Adam Liptak for the New York Times. 23 June 2011 Drug Makers Win Two Supreme Court Decisions
  34. Gayland Hethcoat Regulating Pharmaceutical Marketing After Sorrell v. IMS Health Inc. Quinnipiac Health Law Journal. 2012 Vol. 15:187